|
IMPaCT Trial
Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer. Get Email Updates
Connect with us
  Familial Cancer Cohort
If you would like to be involved in the project please click here to find out more. |
The International Cancer Genome ConsortiumThe APGI is a member of the International Cancer Genome Consortium. The Australian contribution is pancreatic cancer and is co-led by the Garvan Institute in Sydney and the Institute of Molecular Bioscience in Brisbane. Our goal is to map the genome of pancreatic cancer in order to provide scientists and doctors tools to discover new ways to treat pancreatic cancer. |
